[go: up one dir, main page]

AU2002218220A1 - Method for producing powdery formulations - Google Patents

Method for producing powdery formulations

Info

Publication number
AU2002218220A1
AU2002218220A1 AU2002218220A AU2002218220A AU2002218220A1 AU 2002218220 A1 AU2002218220 A1 AU 2002218220A1 AU 2002218220 A AU2002218220 A AU 2002218220A AU 2002218220 A AU2002218220 A AU 2002218220A AU 2002218220 A1 AU2002218220 A1 AU 2002218220A1
Authority
AU
Australia
Prior art keywords
producing powdery
powdery formulations
formulations
producing
powdery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002218220A
Other versions
AU2002218220B2 (en
Inventor
Georg Bock
Michael Walz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001138022 external-priority patent/DE10138022A1/en
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority claimed from PCT/EP2001/011636 external-priority patent/WO2002030390A2/en
Publication of AU2002218220A1 publication Critical patent/AU2002218220A1/en
Application granted granted Critical
Publication of AU2002218220B2 publication Critical patent/AU2002218220B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002218220A 2000-10-12 2001-10-09 Method for producing powdery formulations Expired AU2002218220B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
DE10050635.6 2000-10-12
DE10138022.4 2001-08-10
DE2001138022 DE10138022A1 (en) 2001-08-10 2001-08-10 Production of homogeneous inhalation powders comprises introducing alternate layers of large excipient particles and small drug particles into a mixing vessel
PCT/EP2001/011636 WO2002030390A2 (en) 2000-10-12 2001-10-09 Method for producing powdery formulations

Publications (2)

Publication Number Publication Date
AU2002218220A1 true AU2002218220A1 (en) 2002-06-27
AU2002218220B2 AU2002218220B2 (en) 2006-06-15

Family

ID=26007343

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1822002A Pending AU1822002A (en) 2000-10-12 2001-10-09 Method for producing powdery formulations
AU2002218220A Expired AU2002218220B2 (en) 2000-10-12 2001-10-09 Method for producing powdery formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU1822002A Pending AU1822002A (en) 2000-10-12 2001-10-09 Method for producing powdery formulations

Country Status (39)

Country Link
US (2) US6585959B2 (en)
EP (1) EP1326585B2 (en)
JP (2) JP4986369B2 (en)
KR (1) KR100849837B1 (en)
CN (1) CN1269470C (en)
AR (1) AR034166A1 (en)
AT (1) ATE319422T1 (en)
AU (2) AU1822002A (en)
BG (1) BG66194B1 (en)
BR (1) BR0114316A (en)
CA (1) CA2425005C (en)
CY (1) CY1105037T1 (en)
CZ (1) CZ300022B6 (en)
DE (1) DE50109178D1 (en)
DK (1) DK1326585T4 (en)
EA (1) EA004689B1 (en)
EE (1) EE05146B1 (en)
EG (1) EG24478A (en)
ES (1) ES2259046T5 (en)
HR (1) HRP20030277B1 (en)
HU (1) HU229512B1 (en)
IL (2) IL154919A0 (en)
ME (1) ME02762B (en)
MX (1) MXPA03003219A (en)
MY (1) MY155912A (en)
NO (1) NO333719B1 (en)
NZ (1) NZ525781A (en)
PE (1) PE20020424A1 (en)
PL (1) PL204733B1 (en)
PT (1) PT1326585E (en)
RS (1) RS50495B (en)
SA (1) SA01220518B1 (en)
SI (1) SI1326585T2 (en)
SK (1) SK285841B6 (en)
TW (1) TWI283180B (en)
UA (1) UA75375C2 (en)
UY (1) UY26960A1 (en)
WO (1) WO2002030390A2 (en)
ZA (1) ZA200301349B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1430887A1 (en) * 2000-10-12 2004-06-23 Boehringer Ingelheim Pharma GmbH & Co.KG Powder for inhalation containing Tiotropium
US6443152B1 (en) * 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
CA2445650A1 (en) * 2001-05-25 2002-12-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Scattering process for the production of powder formulations
DE10141376A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Process for the preparation of inhalable powders
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
JP2005526103A (en) * 2002-04-04 2005-09-02 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Powder formulation suitable for inhalation
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
EP1599209B1 (en) * 2002-08-21 2011-08-17 Norton Healthcare Limited Inhalation composition
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
JP4744876B2 (en) * 2002-08-21 2011-08-10 ノートン・ヘルスケアー リミテッド Method for producing a dry powder inhalation composition
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium-containing powder formulation for inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
UA83813C2 (en) * 2002-12-20 2008-08-26 Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
DE10317461A1 (en) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
DE10331350A1 (en) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient
ES2362038T3 (en) 2003-09-02 2011-06-27 Norton Healthcare Limited PROCEDURE TO PREPARE A MEDICINAL PRODUCT
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
UA82414C2 (en) 2003-11-03 2008-04-10 Бёрингер Ингельхайм Интернациональ Гмбх Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
ES2342468T3 (en) 2003-11-03 2010-07-07 Boehringer Ingelheim International Gmbh PROCEDURE FOR THE PREPARATION OF TIOTROPE SALTS.
AU2004294890B2 (en) * 2003-12-03 2010-08-26 Boehringer Ingelheim International Gmbh Pre-metered dry powder inhaler for moisture-sensitive medicaments
DE102004048389A1 (en) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modification of surfaces of lactose as adjuvant for use with powder inhalants
CN101155590A (en) 2005-02-10 2008-04-02 葛兰素集团有限公司 Method for preparing lactose using a pre-sorting technique and pharmaceutical formulations formed thereby
GB0507835D0 (en) * 2005-04-18 2005-05-25 Solexa Ltd Method and device for nucleic acid sequencing using a planar wave guide
SI1881980T1 (en) 2005-05-02 2012-12-31 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
DE102005059602A1 (en) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Micronization process
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
CN101765606A (en) * 2007-07-27 2010-06-30 卡吉尔公司 micronization of polyols
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
EP2662027B1 (en) 2008-05-09 2017-09-27 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
WO2010010538A2 (en) * 2008-07-24 2010-01-28 L'air Liquide-Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films
TWI491416B (en) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd A dry powder pharmaceutical composition for inhalation
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
CN104042322B (en) 2009-10-27 2017-06-06 赫莱拉公司 Delivery apparatus with coolable energy transmitting device
EP2842510B1 (en) 2009-11-11 2022-08-24 Nuvaira, Inc. Device for treating tissue and controlling stenosis
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
EP2575786B1 (en) 2010-06-03 2017-11-15 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Process for dry powder formulations
TR201007251A2 (en) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Calcium channel blocker formulation.
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
ES2701525T3 (en) 2014-07-09 2019-02-22 Arven Ilac Sanayi Ve Ticaret As A procedure for the preparation of formulations for inhalation
EP3175842B1 (en) 2015-12-03 2019-12-11 Alfred E. Tiefenbacher (GmbH & Co. KG) Dry powder mixing process
WO2020013793A2 (en) * 2018-07-12 2020-01-16 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising dopamine agonists
WO2022146255A1 (en) * 2020-12-31 2022-07-07 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
BE891013A (en) 1980-11-05 1982-05-05 Fisons Ltd PHARMACEUTICAL COMPOSITIONS
JPS60150823A (en) * 1984-01-17 1985-08-08 Satake Eng Co Ltd grain mixing equipment
JPH0439388A (en) * 1990-06-04 1992-02-10 Teijin Ltd Method for mixing earth and sand with fibrous material
DE4140689B4 (en) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
JPH06198156A (en) * 1993-01-06 1994-07-19 Nagasaki Pref Gov Atomizing and laminating mixer
IS1796B (en) * 1993-06-24 2001-12-31 Ab Astra Inhaled polypeptide formulation composition which also contains an enhancer compound
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (en) 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
DE59914603D1 (en) 1998-11-13 2008-02-14 Jagotec Ag Multidose dry powder inhaler with powder reservoir
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
AU2002218220A1 (en) Method for producing powdery formulations
AU1822002A (en) Method for producing powdery formulations
AU2002224154A1 (en) Method for producing polybutene
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001239243A1 (en) Method for producing nanosuspensions
AU2001263004A1 (en) System for continuously producing gum
AU2001291882A1 (en) Method for producing polyisobutylphenols
AU2001233699A1 (en) Method for selecting products
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2001225621A1 (en) Method for producing nitrogenous-potash fertiliser
AU2001274958A1 (en) Filling method
EP1298117A3 (en) Method for preparing bromofluorenes
AU3734301A (en) Method for producing 2-chloro-benzimidazole derivatives
AU2001237530A1 (en) Method
AU2001294449A1 (en) Method for producing an antineoplastic
AU2001241636A1 (en) Halotherapy method
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001295658A1 (en) Method for 3d adaptation
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU1141501A (en) Method for producing hydroxymethylpyridines
AU1283001A (en) Method for producing alkylhalogenosilanes
AU2562001A (en) Method for producing nitrogenous-potash fertiliser
AU2001287723A1 (en) Method for producing delta 1-pyrrolines
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol